Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 352 for:    psychiatric | Not yet recruiting Studies

Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03811964
Recruitment Status : Not yet recruiting
First Posted : January 22, 2019
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
The light has visual and non-visual effects on organism and can act on the behavior, the mood, the cognition and the sleep. These effects are mediated by "classical" retina photoreceptors which allow vision (rods, cones) but also melanopsin cells. The non-visual effects of light seems to be altered in many neurological, psychiatric or ophtalmological conditions but their exact role in the pathogenesis remains poorly understand. The purpose of the study is to increase our knowledge of the non-visual effects of light and establish new therapeutic applications

Condition or disease Intervention/treatment Phase
Sleep Disorders Neurological Pathologies Psychiatric Pathologies Ophthalmological Pathologies Other: Specific light exposures Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 726 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Study of the Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies
Estimated Study Start Date : December 15, 2019
Estimated Primary Completion Date : September 15, 2023
Estimated Study Completion Date : September 15, 2023

Arm Intervention/treatment
primary sleep-wake disorder
Subjects with primary sleep-wake disorder
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens

neurological pathology
subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens

psychiatric pathology
subject presenting a psychiatric pathology with disorder of the controls of the wake and the sleep
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens

ophthalmological pathology
subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens

photosensitivity
subjects with photosensitivity with regulation disorder of sleep and wake
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens

group control
healthy subject
Other: Specific light exposures
Specific light exposures using light in a wide range of intensities or different light/dark regimens




Primary Outcome Measures :
  1. PIPR : Post-Illumination Pupil Response [ Time Frame: 1 day ]
    1 measurement per subject is performed after exposure to monochromatic light exposure



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Man or woman
  • Aged 18 years or older
  • Subject having signed a free and informed consent
  • Subject affiliated to a social protection scheme Arm 1 :Subjects with primary sleep-wake disorder Arm 2 : subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep Arm 3 : subject presenting a psychiatric pathology pathology with disorder of the controls of the wake and the sleep Arm 4 : subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction Arm 5 : subjects with photosensitivity with regulation disorder of sleep and wake Arm 6 : healthy subject

Exclusion Criteria:

Age-Related Macular Degeneration (AMD) and all maculopathies (retinopathies pigmentosa, macular involvement of diabetes)

  • Cataract with significant vision loss <5/10
  • Chorioretinal neovascularization
  • Subject in exclusion period determined by previous or current study
  • Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship
  • Pregnancy / Breastfeeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03811964


Contacts
Layout table for location contacts
Contact: Bourgin Patrice, MD 03 88 11 64 30 ext 0033 pbourgin@unistra.fr

Locations
Layout table for location information
France
University Hospital, Strasbourg, France
Strasbourg, France, 67000
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Principal Investigator: Bourgin Patrice, MD University Hospital, Strasbourg, France

Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03811964    
Other Study ID Numbers: 6791
First Posted: January 22, 2019    Key Record Dates
Last Update Posted: August 22, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Sleep Wake Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders